19-1108264-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014963.3(SBNO2):c.4057A>T(p.Ile1353Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000686 in 1,522,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00073 ( 0 hom. )
Consequence
SBNO2
NM_014963.3 missense
NM_014963.3 missense
Scores
3
4
11
Clinical Significance
Conservation
PhyloP100: 1.32
Genes affected
SBNO2 (HGNC:29158): (strawberry notch homolog 2) Predicted to enable chromatin DNA binding activity and histone binding activity. Involved in several processes, including cellular response to interleukin-6; macrophage activation involved in immune response; and negative regulation of transcription, DNA-templated. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06602043).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBNO2 | NM_014963.3 | c.4057A>T | p.Ile1353Phe | missense_variant | 32/32 | ENST00000361757.8 | NP_055778.2 | |
SBNO2 | NM_001100122.2 | c.3886A>T | p.Ile1296Phe | missense_variant | 29/29 | NP_001093592.1 | ||
SBNO2 | XM_047438466.1 | c.2860A>T | p.Ile954Phe | missense_variant | 29/29 | XP_047294422.1 | ||
SBNO2 | XM_011527804.4 | c.*387A>T | 3_prime_UTR_variant | 32/32 | XP_011526106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SBNO2 | ENST00000361757.8 | c.4057A>T | p.Ile1353Phe | missense_variant | 32/32 | 1 | NM_014963.3 | ENSP00000354733.2 | ||
SBNO2 | ENST00000587024.5 | c.4027A>T | p.Ile1343Phe | missense_variant | 32/32 | 2 | ENSP00000468520.1 | |||
SBNO2 | ENST00000438103.6 | c.3886A>T | p.Ile1296Phe | missense_variant | 29/29 | 2 | ENSP00000400762.1 |
Frequencies
GnomAD3 genomes AF: 0.000304 AC: 46AN: 151508Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
46
AN:
151508
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000160 AC: 20AN: 124764Hom.: 0 AF XY: 0.000132 AC XY: 9AN XY: 68400
GnomAD3 exomes
AF:
AC:
20
AN:
124764
Hom.:
AF XY:
AC XY:
9
AN XY:
68400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000729 AC: 999AN: 1371058Hom.: 0 Cov.: 30 AF XY: 0.000690 AC XY: 467AN XY: 676710
GnomAD4 exome
AF:
AC:
999
AN:
1371058
Hom.:
Cov.:
30
AF XY:
AC XY:
467
AN XY:
676710
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000304 AC: 46AN: 151508Hom.: 0 Cov.: 33 AF XY: 0.000297 AC XY: 22AN XY: 74024
GnomAD4 genome
AF:
AC:
46
AN:
151508
Hom.:
Cov.:
33
AF XY:
AC XY:
22
AN XY:
74024
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2023 | The c.4057A>T (p.I1353F) alteration is located in exon 32 (coding exon 31) of the SBNO2 gene. This alteration results from a A to T substitution at nucleotide position 4057, causing the isoleucine (I) at amino acid position 1353 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Pathogenic
D;D;.
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at